ロード中...
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local failure suggests the efficacy of RT needs to be impr...
保存先:
| 出版年: | Neurooncol Pract |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274183/ https://ncbi.nlm.nih.gov/pubmed/32537176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz057 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|